Tilray Begins Exporting Medicinal-Cannabis Extract to South Africa

The British Columbia based company, Tilray, has added South Africa to the list of countries to whom it is exporting made-in-B.C. medicinal cannabis and extracts.  The company already exports its products to the European Union, New Zealand and Australia.

Tilray, a Nanaimo-based company, became the first Canadian company to legally export medicinal cannabis when it began shipping to partners in Europe in June 2016.

The list of countries where Tilray’s medicinal-cannabis is available includes Croatia, the Czech Republic, Germany, Cyprus, Australia, New Zealand, Chile, and now South Africa. The agreement marks Tilray’s first foray into the continent of Africa.

Tilray’s partner in South Africa is BGM Pharmaceuticals. The medicinal-cannabis product being distributed there takes the form of a liquid-extract solution that’s to be taken orally via a dropper bottle.  Tilray’s product is the first cannabinoid-based product derived from the cannabis plant that has ever been legally exported to and made available for medical purposes in the country of South Africa and on the continent of Africa.

Related posts

Aphria Continues International Expansion, Entering the Argentinian Cannabis Market

Editor

Organigram Holdings to Invest $10M into European Hemp Cultivator Eviana Health.

Editor

NexgenRx & CannTrust to Provide Medical Cannabis in Conjunction with Patients Health Care Plans in Canada

Editor

Leave a Comment

%d bloggers like this: